Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice
- PMID: 4039080
- DOI: 10.1016/0378-4274(85)90058-x
Protective effect of metallothionein inducing metals on lethal toxicity of cis-diamminedichloroplatinum in mice
Abstract
A protective effect of preadministration of the metals Cu, Bi, Zn, Hg, Cd, Ni or Co, against lethal toxicity of cis-diamminedichloroplatinum (Cisplatin; CDDP) was observed in mice. However, the protective effect seems not always to correlate with metallothionein (MT) levels in the liver and kidney of mice treated with one of these metals, suggesting possible participation in this protection of mechanisms other than MT induction by the preadministered metals.
Similar articles
-
Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor.Anticancer Res. 1992 Nov-Dec;12(6B):2303-7. Anticancer Res. 1992. PMID: 1295477
-
Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.Cancer Res. 1987 Feb 15;47(4):983-7. Cancer Res. 1987. PMID: 3802104
-
Effect of preinduction of metallothionein on paraquat toxicity in mice.Arch Toxicol. 1992;66(2):145-8. doi: 10.1007/BF02342510. Arch Toxicol. 1992. PMID: 1605731
-
Alteration of radiosensitivity in metallothionein induced mice and a possible role of Zn-Cu-thionein in GSH-peroxidase system.Experientia Suppl. 1987;52:603-12. doi: 10.1007/978-3-0348-6784-9_63. Experientia Suppl. 1987. PMID: 2959551 Review.
-
Induction of metallothionein as an adaptive mechanism affecting the magnitude and progression of toxicological injury.Environ Health Perspect. 1998 Feb;106 Suppl 1(Suppl 1):297-300. doi: 10.1289/ehp.98106s1297. Environ Health Perspect. 1998. PMID: 9539022 Free PMC article. Review.
Cited by
-
Zinc acetate pretreatment ameliorates cisplatin-induced Sertoli cell dysfunction in Sprague-Dawley rats.Cancer Chemother Pharmacol. 1989;24(3):177-80. doi: 10.1007/BF00300239. Cancer Chemother Pharmacol. 1989. PMID: 2500265
-
Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.Cancer Chemother Pharmacol. 1988;21(2):176-8. doi: 10.1007/BF00257369. Cancer Chemother Pharmacol. 1988. PMID: 3349566
-
Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.Cancer Chemother Pharmacol. 1990;25(6):411-7. doi: 10.1007/BF00686051. Cancer Chemother Pharmacol. 1990. PMID: 2311168
-
Experimental basis for increasing the therapeutic index of cis-diamminedicarboxylatocyclobutaneplatinum(II) in brain tumor therapy by a high-zinc diet.Cancer Chemother Pharmacol. 1992;29(3):219-26. doi: 10.1007/BF00686256. Cancer Chemother Pharmacol. 1992. PMID: 1733555
-
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.Cancer Chemother Pharmacol. 1993;33(2):93-106. doi: 10.1007/BF00685326. Cancer Chemother Pharmacol. 1993. PMID: 8261581 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources